| Literature DB >> 23914977 |
Renu Goel1,2, Krishna R Murthy1,3,4, Srinivas M Srikanth1,5, Sneha M Pinto1,6, Mitali Bhattacharjee1,3, Dhanashree S Kelkar1,3, Anil K Madugundu1, Gourav Dey1, Sujatha S Mohan1,2,7, Venkatarangaiah Krishna2, Ts Keshava Prasad1,3,6, Shukti Chakravarti8,9,10, H C Harsha1, Akhilesh Pandey8,11.
Abstract
BACKGROUND: The ciliary body is the circumferential muscular tissue located just behind the iris in the anterior chamber of the eye. It plays a pivotal role in the production of aqueous humor, maintenance of the lens zonules and accommodation by changing the shape of the crystalline lens. The ciliary body is the major target of drugs against glaucoma as its inhibition leads to a drop in intraocular pressure. A molecular study of the ciliary body could provide a better understanding about the pathophysiological processes that occur in glaucoma. Thus far, no large-scale proteomic investigation has been reported for the human ciliary body.Entities:
Year: 2013 PMID: 23914977 PMCID: PMC3750387 DOI: 10.1186/1559-0275-10-9
Source DB: PubMed Journal: Clin Proteomics ISSN: 1542-6416 Impact factor: 3.988
Figure 1Schematic structure of the eye and experimental strategy for proteomic analysis of human ciliary body. Panel A. shows anatomy of the eye with a zoomed in view of the ciliary body. Panel B. depicts the proteomic workflow employed for the study.
A summary of published studies for the ciliary body protein identification
| 1 | Wu | Immunohistochemistry, Western blot | PCE and NPCE cells | NOS1 |
| 2 | Wu | Immunohistochemistry, Western blot | PCE and NPCE cells | NOS2 |
| 3 | Wu | Immunohistochemistry, Western blot | PCE and NPCE cells | NOS3 |
| 4 | Krueger | Immunohistochemistry | PCE and NPCE cells | SCNN1B |
| 5 | Krueger | Immunohistochemistry | PCE and NPCE cells | SCNN1G |
| 6 | Gabriel | Immunohistochemistry, Western blot | Ciliary body | ADAMTSL4 |
| 7 | Yamanouchi | Immunofluorescence, immunohistochemical assay | NPCE | FBN1 |
| 8 | Yamanouchi | Immunofluorescence, immunohistochemical assay | NPCE | FBN2 |
| 9 | Chowdhury | Immunohistochemistry, Western blot | Ciliary body | SPP1 |
| 10 | Russell-Randall | Immunofluorescence | NPCE | OPRK1 |
| 11 | Zhang | immunofluorescence | NPCE | BEST2 |
| 12 | Kraft | Immunofluorescence | PCE and NPCE cells | SLCO2A1 |
| 13 | Kraft | Immunofluorescence | PCE and NPCE cells | SLCO2B1 |
| 14 | Wang | Immunohistochemistry | NPCE | COX2 |
| 15 | Flugel-Koch | Immunohistochemical | Ciliary body | TH |
| 16 | Flugel-Koch | Immunohistochemical | Ciliary body | NPY |
| 17 | Flugel-Koch | Immunohistochemical | Ciliary body | TAC1 |
| 18 | Flugel-Koch | Immunohistochemical | Ciliary body | SLC18A3 |
| 19 | Flugel-Koch | Immunohistochemical | Ciliary body | NOS1 |
| 20 | Flugel-Koch | Immunohistochemical | Ciliary body | CALB2 |
| 21 | Flugel-Koch | Immunohistochemical | Ciliary body | CALCA |
| 22 | Flugel-Koch | Immunohistochemical | Ciliary body | DECR1 |
| 23 | Yucel | Immunofluorescence | Ciliary body | PDPN |
| 24 | Yucel | Immunofluorescence | Ciliary body | LYVE1 |
| 28 | Mao | Immunohistochemical | NPCE cells | SH3PXD2B |
| 29 | Ooi | Western blot, Immunofluorescence | Ciliary body | ADRA2A |
| 30 | Webb | Immunofluorescence and immunoblot | NPCE | KLK1 |
| 31 | Webb | Western blot | Ciliary body | BDKRB1 |
| 32 | Webb | Western blot | Ciliary body | BDKRB2 |
| 33 | Pattwell | Immunofluorescence | NPCE | Opticin |
| 34 | Pattwell | Immunofluorescence | NPCE | COL2A1 |
| 35 | Pecorella | Immunohistochemistry | Ciliary body | ENO2 |
| 36 | Pecorella | Immunohistochemistry | Ciliary body | S100B |
| 37 | Pecorella | Immunohistochemistry | Ciliary body | VIM |
| 38 | Marmorstein | Immunofluorescence | NPCE | BEST2 |
| 39 | Ostojic | Immunofluorescence | NPCE | CYGB |
| 40 | Ostojic | Immunofluorescence | NPCE | NGB |
| 41 | Assheton | Immunofluorescence | NPCE | Opticin |
| 42 | Toyran | Immunohistochemistry | NPCE | BMP7 |
| 43 | Toyran | Immunohistochemistry | NPCE | GDF5 |
| 44 | Maatta | Immunohistochemistry | PCE and NPCE cells | COL18A1 |
| 45 | Ohlmann | Immunohistochemistry | NPCE | COL18A1 |
| 46 | Ramesh | Immunolocalisation | Ciliary body | Opticin |
| 47 | Ramesh | Immunolocalisation | Ciliary body | COL18A1 |
| 48 | Bishop | in situ hybridisation | NPCE | Opticin |
| 49 | Wollensak | Immunohistochemistry | Ciliary body | ECE1 |
| 50 | Doshi | Immunoreactivity | NPCE | CYP1B1 |
| 51 | Sonsino | Immunofluorescence | NPCE | TJP1 |
| 52 | Sonsino | Immunofluorescence | NPCE | OCLN |
| 53 | Hamann | Immunohistochemistry | Ciliary body | AQP1 |
| 54 | Wang | Immunoreactivity | Ciliary body | LAMB1 |
| 55 | Wang | Immunoreactivity | Ciliary body | LAMB2 |
| 56 | Kumagai | Immunohistochemistry | NPCE | SLC2A1 |
| 57 | Peress | Immunohistochemical | PCE and NPCE cells | TGFB2 |
| 58 | Peress | Immunohistochemical | PCE and NPCE cells | TGFB3 |
| 59 | Wistrand | Immunofluorescence | PCE and NPCE cells | CA2 |
Figure 2MS/MS spectra of previously described proteins. A. The peptide IDLSNNLISSIDNDAFR from opticin B. shows the MS/MS spectra of peptide TEAPSATGQASSLLGGR from collagen, type XVIII, alpha 1 C. The Peptide QVLEGHVLSEAR belongs to cytochrome p450 1B1 D. VWTSGQVEEYDLDADDINSR peptide from aquaporin 1.
A partial list of novel proteins identified in this study
| P4HB | Calpain small subunit 1 | Endoplasmic reticulum | Protein metabolism | Isomerase activity |
| Golgi apparatus protein 1 | Golgi apparatus | Biological_process unknown | Receptor binding | |
| Leukocyte surface antigen CD47 | Cell surface, Plasma membrane | Immune response | Molecular function unknown | |
| ER lumen protein retaining receptor 2 | Endoplasmic reticulum | Transport | Transporter activity | |
| Neutrophil cytosol factor 2 | Cytoplasm | Metabolism, Energy pathways | Catalytic activity | |
| Profilin-1 | Cytoplasm | Cell growth | Cytoskeletal protein binding | |
| Myosin-11 | Mitochondrion | Metabolism, Energy pathways | Catalytic activity | |
| Pyruvate kinase isozymes M1/M2 | Cytoplasm | Metabolism, Energy pathways | Oxidoreductase activity | |
| Tubulin beta-2A chain | Extracellular | Transport | Transporter activity | |
| 78 kDa glucose-regulated protein | Endoplasmic reticulum | Protein metabolism | Chaperone activity | |
| Elongation factor 1-alpha 1 | Cytoplasm | Regulation of cell cycle | Transcription regulator activity | |
| Alpha-1-antitrypsin | Cytoplasm | Metabolism, Energy pathways | Hydrolase activity | |
| Complement C3 | Extracellular | Immune response | Complement activity | |
| NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial | Golgi apparatus | Cell communication, Signal transduction | GTPase activity |
Figure 3MS/MS spectra of novel proteins identified. A. shows the MS/MS spectra of peptide, EEAENNLAAFR, from Desmin B. The peptide, GAEILEVLHSLPAVR, derived from 26S proteasome non-ATPase regulatory subunit 6 C. NVDILKDPETVK Peptide from exportin-1 D. SEDPDQQYLILNTAR Peptide from vacuolar sorting-associated protein 35.
Figure 4Comparison of the ciliary body proteome with the aqueous humor and plasma proteome. Panel A shows comparison of the ciliary body proteins with plasma proteins annotated in the Plasma Proteome Database. Panel B depicts comparison of the ciliary body proteome with aqueous humor proteome annotated from the published literature. Panel C shows a comparison of proteins that are common to the ciliary body and plasma with those that are common to the ciliary body and the aqueous humor.
Figure 5Subcellular localization and functional annotation of proteins identified from the ciliary body. A. Gene Ontology analysis for subcellular localization of identified proteins B. Molecular function of identified proteins C. Biological processes of the identified proteins. The data regarding proteins was obtained from Human Protein Reference Database (http://www.hprd.org).
Details of Ingenuity Pathways Analysis (IPA) of top ten canonical pathways
| Ubiquitination pathway | 2.01E-14 | 94/263 |
| tRNA charging | 2.63E-14 | 28/38 |
| EIF2 signaling | 3.36E-12 | 68/182 |
| Glycolysis I | 1.2E-11 | 19/23 |
| Gluconeogenesis | 4.84E-11 | 19/24 |
| Valine degradation | 5.96E-11 | 16/18 |
| Ethanol degradation | 2.32 E-10 | 21/30 |
| Caveolar mediated endocytosis signaling | 7.56 E-10 | 35/81 |
| Integrin signaling | 1.23 E-09 | 68/205 |
| TCA cycle | 3.32 E-09 | 17/23 |
Clinical details of donors used in this study
| CB01 | 80 | Female | Indian |
| CB02 | 94 | Female | Indian |
| CB03 | 89 | Male | Indian |